Skin Graft Study
Protocol: STUDY00002856
Full Title
Effectiveness of liposomal bupivacaine for split thickness donor sites: a prospective, randomized trial.
Description
The purpose of this study is to learn more about which local anesthetic offers the most pain relief for patients receiving a split thickness skin graft.

You will be in this research study for 7-10 days following your surgery. You will be given Exparel (the study medication) or Standard of Care medication (Lidocaine or Saline) at your skin graft donor site. After surgery, you will be asked to fill out surveys four times a day while in the hospital, and three times a day at home for the week following your surgery. These surveys will include what pain medication you needed as well as how bad your pain was at each interval. At your post-operative clinic visit, we will collect this information.

Compensation is not available.

Technical Description

This study is comparing 3 different injections for reducing post-operative pain from split thickness skin graft (STSG) donor sites.
Compensation: No
Eligibility
-Adults ages 18+.
-Undergoing a surgery including split thickness skin graft.
Age Group: Adults
Principal Investigator: MARK BURKE
Contact(s)
JAMES ZEMER
jameszem@buffalo.edu
+1 716-645-2521
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.